Education
About Us
Working with TipRanks
Follow Us
Lee Kalowski Insider Profile
4 Followers
Lee Kalowski, CFO at Eledon Pharmaceuticals, holds 49.01K shares in Q32 Bio (Ticker: QTTB), holds 30.31K shares in Bicycle Therapeutics (Ticker: BCYC), holds 40.95K shares in Eledon Pharmaceuticals (Ticker: ELDN). Most recently, Lee Kalowski Sold ― shares of Q32 Bio on Aug 28, 2025 for an estimated value of $7.63K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-21.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lee Kalowski holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jan 05, 2023 - Jan 05, 2024
Return:+45.20%
The most profitable trade made by Lee Kalowski
Lee Kalowski's Trading History
Eledon Pharmaceuticals
Sep 08, 2015
CFO
Uninformative Sell
61.29K
$140.88K
Bicycle Therapeutics
Apr 05, 2023
Pres. & CFO
Informative Sell
7.94K
$247.62K
Q32 Bio
Aug 28, 2025
CFO and President
Informative Sell
7.63K
$155.36K
List of latest transactions for each holding click on a transaction to see Lee Kalowski's performance on stock
You May Also Like
Lee Kalowski insider profile FAQ
What is the percentage of profitable transactions made by Lee Kalowski?
The percentage of profitable transactions made by Lee Kalowski is 33%.
What is the average return per transaction made by Lee Kalowski?
The average return per transaction made by Lee Kalowski is -21.10%.
What stocks does Lee Kalowski hold?
Lee Kalowski holds: ELDN, BCYC, QTTB stocks.
What was Lee Kalowski’s latest transaction?
Lee Kalowski latest transaction was an Informative Sell of $7.63K.
What was Lee Kalowski's most profitable transaction?
Lee Kalowski’s most profitable transaction was an Informative Sell of BCYC stock on January 5, 2023. The return on the trade was 45.20%.
What is Lee Kalowski's role in Eledon Pharmaceuticals?
Lee Kalowski's role in Eledon Pharmaceuticals is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.